Mechanisms of acquired resistance to 2-(4-aminophenyl)benzothiazole (CJM 126, NSC 34445)

British Journal of Cancer

Volumn 83, Issue 2, 2000, Pages 270-277

  Bradshaw, T D ^a   Chua, M S ^a   Orr, S ^a   Matthews, C S ^a   Stevens, M F G ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

2 (4 Aminophenyl)benzothiazole; MCF 7, acquired resistance

Indexed keywords

2 (4 AMINO 3 METHYLPHENYL)BENZOTHIAZOLE; ACYLTRANSFERASE; BENZO[A]PYRENE; BENZOTHIAZOLE DERIVATIVE; CJM 126; CYTOCHROME P450; DACTINOMYCIN; DF 129; DF 229; DNA; DOXORUBICIN; ESTROGEN RECEPTOR; MITOMYCIN C; NSC 34445; PROTEIN BCL 2; PROTEIN P53; TAMOXIFEN; UNCLASSIFIED DRUG;

ACETYLATION; ANTINEOPLASTIC ACTIVITY; ARTICLE; BIOTRANSFORMATION; BREAST CANCER; BREAST CARCINOMA; CANCER CELL CULTURE; CELL GROWTH; CELL STRAIN MCF 7; COLON CANCER; CONTROLLED STUDY; CROSS RESISTANCE; CYTOPLASM; DNA STRAND BREAKAGE; DRUG ACTIVITY; DRUG DISTRIBUTION; GROWTH INHIBITION; HUMAN; HUMAN CELL; KIDNEY CANCER; METABOLITE; OVARY CANCER; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SOLID TUMOR;

ANTINEOPLASTIC AGENTS; ARYLAMINE N-ACETYLTRANSFERASE; BENZOTHIAZOLES; BIOTRANSFORMATION; CELL DIVISION; CULTURE MEDIA; CYTOCHROME P-450 CYP1A1; DNA DAMAGE; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION; HUMANS; ISOENZYMES; THIAZOLES; TUMOR CELLS, CULTURED;

EID: 0034049570     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjoc.2000.1231     Document Type: Article

References (24)

1. Akman SA, Forrest G, Chu FF, Esworthy S and Doroshow JH (1990) Antioxidant and xenobiotic-metabolizing enzyme gene expression in doxorubicin-resistant human breast cancer cells. Cancer Res 50: 1397-1402
2. Batist G, Tulpules A, Sinha BK, Katki AG, Myers CE and Cowan KH (1986) Overexpression of a novel anionic glutathione transferase in multi-drug resistant human breast cancer cells. J Biol Chem 261: 15544-15549
3. Birnboim HC and Jevcak JJ (1981) Fluorometric method for rapid detection of DNA strand breaks in human white blood cells produced by low doses of radiation. Cancer Res 41: 1889-1892
4. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254
5. Bradshaw TD, Wrigley S, Shi D-F, Schultz RJ, Paull KD and Stevens MFG (1998a) 2-(4-Aminophenyl)benzothiazoles: novel agents with selective profiles of in vitro antitumour activity. Br J Cancer 77: 745-752
6. Bradshaw TD, Shi D-F, Schultz RJ, Paull KD, Kelland L, Wilson A, Garner C, Fiebig HH, Wrigley S and Stevens MFG (1998b) Influence of 2-(4-aminophenyl)benzothiazoles on growth of human ovarian carcinoma cells in vitro and in vivo. Br J Cancer 78: 421-429
7. Caruso JA and Batist G (1999) Divergent mechanisms for loss of Ah-responsiveness in benzo[a]pyrene-and adriamycin-resistant MCF-7 cells. Biochem Pharmacol 57: 1253-1263
8. Chua M-S, Shi D-F, Wrigley S, Bradshaw TD, Hutchinson I, Shaw PN, Barrett DA, Stanley L, Sausville EA and Stevens MFG (1999) Antitumour Benzothiazoles. 7. Synthesis of 2-(4-acylaminophenyl)benzothiazoles and investigations into the role of acetylation in the antitumor activities of the parent amines. J Med Chem 42: 381-392
9. Chua M-S, Kashiyama E, Bradshaw TD, Stinson SF, Brantley E, Sausville EA and Stevens MFG. Role of CYPIAI in modulation of antitumour properties of the novel agent 2-(4-amino-3-methyl-phenyl) benzothiazole (DF 203, NSC 674495) in human breast cancer cells. Cancer Research (submitted)
10. Crofts FG, Sutter TR and Strickland PT (1998) Metabolism of 2-amino-1-methyl-6-phenylimdazo [4, 5-6] pyridine by human cytochrome P45501A1, P4501A2 and P4501B1. Carcinogenesis 19: 1969-1973
11. Hayes JD and Wolf CR (1990) Molecular mechanisms of drug resistance. Biochem J 272: 281-295
12. Ivy SP, Tulpule A, Fairchild CR, Averbuch SD, Myers CE, Nebert DW, Baird WM abd Cowan KH (1988) Altered regulation of P-4501A1 expression in a multidrug-resistant MCF-7 human breast cancer cell line. J Biol Chem 263: 19119-19125
13. Kashiyama E, Hutchinson I, Chua M-S, Stinson SF, Phillips LR, Kaur G, Sausville EA, Bradshaw TD, Westwell AD and Stevens MFG (1999) Antitumor benzothiazoles 8. Synthesis, metabolic formation and biological properties of antitumor 2-(4-aminophenyl)benzothiazoles. J Med Chem 42: 4172-4184
14. Kinzler KW and Vogelstein B (1994) Clinical implications of basic research: Cancer therapy meets p53. New Engl J Med 331: 49-50
15. Kress S and Greenlee WF (1997) Cell-specific regulation of human CYPIA1 and CYPIB1 genes. Cancer Res 57: 1264-1269
16. Malcomson RDG, Oren M, Wyllie AH and Harrison DJ (1995) p53-Independent death and p53-induced protection against apoptosis in fibroblasts treated with chemotherapeutic drugs. Br J Cancer 72: 952-957
17. Pastrakuljic A, Tang BK, Roberts EA and Kalow W (1997) Distinction of CYP1AI and CYP1A2 activity by selective inhibition using fluvoxamine and isosafrole. Biochem Pharmacol 53: 531-538
18. Pelkonen O and Raunio H (1997) Metabolic activation of toxins: tissue-specific expression and metabolism in target organs. Env Health Perspectives 105: 767-774
19. Sadrieh N, Davis CD and Snyderwine EG (1996) N-acetyltransferase expression and metabolic activation of the food-derived heterocyclic amines in the human mammary gland. Cancer Res 56: 2683-2687
20. Shi DF, Bradshaw TD, Wrigley S, McCall CJ, Lelieveld P, Fichtner I, and Stevens MFG (1996) Antitumour benzothiazoles. 3. Synthesis of 2-(4-aminophenyl)benzothiazoles and evaluation of their activities against breast cancer cell lines in vitro and in vivo. J Med Chem 37: 3375-3384
21. Sinha BK, Katki AG, Batist G, Cowan KH and Myers CE (1987) Differential formation of hydroxyl radicals by adriamycin in sensitive and resistant MCF-7 human breast tumour cells: Implications for the mechanism of action. Biochem 26: 3776-3781
22. Stacey M, Thygesen P, Stanley L, Matas N, Risch A and Sim E (1996) Arylamine N-acetyltransferase as a potential biomarker in bladder cancer: fluorescent in situ hybridization and immunohistochemistry studies. Biomarkers 1: 55-61
23. Stevens MFG, McCall CJ, Lelieveld P, Alexander P, Richter A and Davies DE (1994) Structural studies on bioactive compounds. 23. Synthesis of polyhydroxylated 2-phenylbenzothiazoles and a comparison of their cytotoxicities and pharmacological properties with genistein and quercetin. J Med Chem 37: 1689-1695
24. Weinstein JR, Myers TG, O'Connor PM, Friend SH, Fornace AJF, Kohn KW, Fojo T, Bates SE, Rubinstein LV, Anderson NL, Buolamwini JK, Vanosdol WW, Monks AP, Scudiero DA, Sausville EA, Zaharevitz DW, Bunow B, Viswanadhan VN, Johnson GS, Wittes RE and Paull KD (1997) An information-intensive approach to the molecular pharmacology of cancer. Science 275: 343-349